Oncology Medical News about metastatic breast cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bevacizumab for salvage treatment of metastatic breast cancer: a systemic review and meta-analysis of randomized controlled trials
Investigational New Drugs, 10/08/09

Lee J–B et al. – Meta–analysis suggested benefits of a carefully managed bevacizumab–containing salvage regimen for patients with histologically or cytologically confirmed Her–2 negative MBC who have not received previous cytotoxic therapy. This treatment could improve both progression free survival and overall survival rates.

<< Previous
Risk of relapse of childhood acute lymphoblastic leukemia is...

Next >>
Phase I clinical and pharmacokinetic study of sorafenib in...